Urolithin B protects PC12 cells against glutamate-induced toxicity
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09236-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Israa Aljabouri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Glutamic Acid, Neuroprotective Agents, Coumarins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Mashhad University of Medical Sciences.
Abstract (Originalsprache)
BACKGROUND: The involvement of malfunctioning glutamate systems in various central nervous system (CNS) disorders is widely acknowledged. Urolithin B, known for its neuroprotective and antioxidant properties, has shown potential as a therapeutic agent for these disorders. However, little is known about its protective effects against glutamate-induced toxicity in PC12 cells. Therefore, in this study, for the first time we aimed to investigate the ability of Urolithin B to reduce the cytotoxic effects of glutamate on PC12 cells. METHODS: Different non-toxic concentrations of urolithin B were applied to PC12 cells for 24 h before exposure to glutamate (10 mM). The cells were then analyzed for cell viability, intracellular reactive oxygen species (ROS), cell cycle arrest, apoptosis, and the expression of Bax and Bcl-2 genes. RESULTS: The results of MTT assay showed that glutamate at a concentration of 10 mM and urolithin B at a concentration of 114 μM can reduce PC12 cell viability by 50%. However, urolithin B at non-toxic concentrations of 4 and 8 μM significantly reduced glutamate-induced cytotoxicity (p < 0.01). Interestingly, treatment with glutamate significantly enhanced the intracellular ROS levels and apoptosis rate in PC12 cells, while pre-treatment with non-toxic concentrations of urolithin B significantly reduced these cytotoxic effects. The results also showed that pre-treatment with urolithin B can decrease the Bax (p < 0.05) and increase the Bcl-2 (p < 0.01) gene expression, which was dysregulated by glutamate. CONCLUSIONS: Taken together, urolithin B may play a protective role through reducing oxidative stress and apoptosis against glutamate-induced toxicity in PC12 cells, which merits further investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
- Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. soukhtanloom@mums.ac.ir.
- Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran. soukhtanloom@mums.ac.ir.
Förderung
- Mashhad University of Medical Sciences
Zitieren
APA
Aljabouri, I., Rostami, M., Mirzavi, F., Kakhki, M. K., Alalikhan, A., Gheybi, E., Hakimi, A., & Soukhtanloo, M. (2024). Urolithin B protects PC12 cells against glutamate-induced toxicity. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09236-8
Vancouver
Aljabouri I, Rostami M, Mirzavi F, Kakhki MK, Alalikhan A, Gheybi E, et al. Urolithin B protects PC12 cells against glutamate-induced toxicity. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09236-8
BibTeX
@article{Aljabouri2024,
author = {Aljabouri, Israa and Rostami, Mehdi and Mirzavi, Farshad and Kakhki, Mahla Kazemian and Alalikhan, Abbas and Gheybi, Elaheh and Hakimi, Ali and Soukhtanloo, Mohammad},
title = {Urolithin B protects PC12 cells against glutamate-induced toxicity},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09236-8}
}
EUVIMED